In line, loss of ATGL in the liver either by adenoviral-mediated knockdown or by hepatocyte-specific gene deletion impaired FA oxidation and PPAR-α target gene expression subsequently causing progressive hepatic steatosis [73,117]. The gene discussed is PNPLA2; the disease is fatty liver disease.